These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 14987590)
1. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Collinson PO; Barnes SC; Gaze DC; Galasko G; Lahiri A; Senior R Eur J Heart Fail; 2004 Mar; 6(3):365-8. PubMed ID: 14987590 [TBL] [Abstract][Full Text] [Related]
2. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185 [TBL] [Abstract][Full Text] [Related]
3. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers. Barnes SC; Collinson PO; Galasko G; Lahiri A; Senior R Ann Clin Biochem; 2004 Nov; 41(Pt 6):459-63. PubMed ID: 15588434 [TBL] [Abstract][Full Text] [Related]
5. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)]. Benoit MO; Dautezac F; Taccoen M; Paul JL Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439 [TBL] [Abstract][Full Text] [Related]
8. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy. Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658 [TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
10. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
12. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378 [TBL] [Abstract][Full Text] [Related]
13. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age. Koch AM; Rauh M; Zink S; Singer H Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175 [TBL] [Abstract][Full Text] [Related]
14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART. Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959 [TBL] [Abstract][Full Text] [Related]
16. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Prontera C; Zucchelli GC; Vittorini S; Storti S; Emdin M; Clerico A Clin Chim Acta; 2009 Feb; 400(1-2):70-3. PubMed ID: 18992732 [TBL] [Abstract][Full Text] [Related]
17. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185 [TBL] [Abstract][Full Text] [Related]
18. [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays]. Cauliez B; Boucher S; Duflo-Leroy A; Lavoinne A Ann Biol Clin (Paris); 2007; 65(1):93-8. PubMed ID: 17264046 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998 [TBL] [Abstract][Full Text] [Related]